Swedbank Robur Healthcare
- Namn
- Swedbank Robur Healthcare
- Fondbolag
- Swedbank Robur Fonder AB
- ISIN
- SE0000639445
- Kvartalsslut
- Fondförmögenhet
- 12 577 639 741 SEK
- Likvida medel
- 287 206 124 SEK
- Övriga tillgångar och skulder
- 17 152 521 SEK
- Antal innehav
- 59
- Aktiv risk
- 4,59
- Standardavvikelse 24 månader
- 13,62
- Jämförelseindex
- MSCI World Health Care 10/40 Net
-
Förvaltningsavgift
Healthcare A - 1,25% Fast
-
Förvaltningsavgift
Healthcare C - 1,25% Fast
Största innehav
| Namn | Marknadsvärde | Andel av fondförmögenhet | Bransch |
|---|---|---|---|
| United Health | 1 017 822 333 SEK | 8,09% | Health Care |
| Roche | 707 808 367 SEK | 5,63% | Health Care |
| Thermo Fisher Scientific | 603 591 967 SEK | 4,80% | Health Care |
| AstraZeneca | 557 344 310 SEK | 4,43% | Health Care |
| Abbott Laboratories | 532 113 477 SEK | 4,23% | Health Care |
| Sanofi | 516 060 381 SEK | 4,10% | Health Care |
| Centene | 504 514 899 SEK | 4,01% | Health Care |
| Merck | 501 320 406 SEK | 3,99% | Health Care |
| Horizon Therapeutics | 400 484 831 SEK | 3,18% | Health Care |
| Takeda Pharmaceutical | 352 223 608 SEK | 2,80% | Health Care |
| Amgen | 351 221 891 SEK | 2,79% | Health Care |
| Edward Lifesciences | 301 121 932 SEK | 2,39% | Health Care |
| Novo Nordisk | 298 634 584 SEK | 2,37% | Health Care |
| Livanova | 273 214 911 SEK | 2,17% | Health Care |
| Eli Lilly | 270 426 641 SEK | 2,15% | Health Care |
| Intuitive Surgical | 251 121 288 SEK | 2,00% | Health Care |
| Vertex Pharmaceuticals | 240 497 636 SEK | 1,91% | Health Care |
| Cooper Companies | 235 906 150 SEK | 1,88% | Health Care |
| Swedish Orphan Biovitrum | 231 397 000 SEK | 1,84% | Health Care |
| Hologic | 201 172 735 SEK | 1,60% | Health Care |
| UCB | 197 760 974 SEK | 1,57% | Health Care |
| Viatris | 184 817 724 SEK | 1,47% | Health Care |
| Alexion Pharmaceuticals | 180 916 330 SEK | 1,44% | Health Care |
| Chemometec | 178 195 280 SEK | 1,42% | Health Care |
| Biogen | 173 589 388 SEK | 1,38% | Health Care |
Branscher
Källa: Finansinspektionen.